Search

everythinglearnresearchcommunity

for

Search:↓

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.